DK428280A - Fremgangsmaade til fremstilling af pyridinderivater specielt med antiarytmisk virkning til modvirkning af aggregation af bldplader - Google Patents

Fremgangsmaade til fremstilling af pyridinderivater specielt med antiarytmisk virkning til modvirkning af aggregation af bldplader

Info

Publication number
DK428280A
DK428280A DK428280A DK428280A DK428280A DK 428280 A DK428280 A DK 428280A DK 428280 A DK428280 A DK 428280A DK 428280 A DK428280 A DK 428280A DK 428280 A DK428280 A DK 428280A
Authority
DK
Denmark
Prior art keywords
bladets
antiarithmic
disable
aggregation
procedure
Prior art date
Application number
DK428280A
Other languages
English (en)
Other versions
DK156650C (da
DK156650B (da
Inventor
H Demarne
C Bernhart
J Larsen
Original Assignee
Clin Midy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clin Midy filed Critical Clin Midy
Publication of DK428280A publication Critical patent/DK428280A/da
Priority to DK346086A priority Critical patent/DK346086A/da
Publication of DK156650B publication Critical patent/DK156650B/da
Application granted granted Critical
Publication of DK156650C publication Critical patent/DK156650C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK428280A 1979-10-11 1980-10-10 Analogifremgangsmaade til fremstilling af pyridinderivater, som isaer har en antiarytmisk virkning og modvirker blodpladeaggregation DK156650C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK346086A DK346086A (da) 1979-10-11 1986-07-21 Fremgangsmaade til fremstilling af pyridinderivater, som isaer har en antiarytmisk virkning og modvirker blodpladeaggregation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7925370 1979-10-11
FR7925370A FR2467200A1 (fr) 1979-10-11 1979-10-11 Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Publications (3)

Publication Number Publication Date
DK428280A true DK428280A (da) 1981-04-12
DK156650B DK156650B (da) 1989-09-18
DK156650C DK156650C (da) 1990-02-12

Family

ID=9230594

Family Applications (1)

Application Number Title Priority Date Filing Date
DK428280A DK156650C (da) 1979-10-11 1980-10-10 Analogifremgangsmaade til fremstilling af pyridinderivater, som isaer har en antiarytmisk virkning og modvirker blodpladeaggregation

Country Status (26)

Country Link
US (1) US4356177A (da)
EP (1) EP0027412B1 (da)
JP (1) JPS5661355A (da)
AR (2) AR231129A1 (da)
AT (1) ATE5561T1 (da)
AU (1) AU540556B2 (da)
BR (1) BR8006547A (da)
CA (1) CA1156653A (da)
CS (2) CS225823B2 (da)
DD (1) DD153549A5 (da)
DE (1) DE3065906D1 (da)
DK (1) DK156650C (da)
ES (1) ES495745A0 (da)
FI (1) FI75339C (da)
FR (1) FR2467200A1 (da)
GR (1) GR69616B (da)
HU (1) HU184330B (da)
IE (1) IE50827B1 (da)
IL (1) IL61250A (da)
NO (1) NO153849C (da)
NZ (1) NZ195233A (da)
PH (1) PH18748A (da)
PT (1) PT71888B (da)
SU (2) SU1011048A3 (da)
YU (2) YU42537B (da)
ZA (1) ZA806180B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2535722B1 (fr) * 1982-11-08 1985-06-28 Sanofi Sa Derives de la g-butyrolactone protecteurs du myocarde presentant une activite antiarythmique, procede pour leur preparation et medicaments en contenant
FR2535721A1 (fr) * 1982-11-08 1984-05-11 Sanofi Sa Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives
US4783537A (en) * 1985-11-13 1988-11-08 Pennwalt Corporation α-(aminoalkyl)-arylacetic acid derivatives
US4847301A (en) * 1985-11-13 1989-07-11 Pennwalt Corporation Methods of use of α-(aminoalkyl)-arylacetic acid derivatives
FR2856061A1 (fr) * 2003-06-11 2004-12-17 Chrysalon Derives polycycliques ortho-condenses de l'aminopyrrole a substituant electroattracteur chimiotheques combinatoires desdits derives et leur procede d'obtention

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL70757C (da) * 1947-10-13
GB915804A (en) * 1958-04-12 1963-01-16 Degussa Process for the production of basically substituted carboxylic acid amides
FR2485M (fr) * 1961-05-17 1964-04-27 Searle & Co Nouveaux régulateurs cardiaques.
CA1073892A (en) * 1976-08-03 1980-03-18 John M. Holmes Mixed metal amide catalysts for h-d exchange in amines

Also Published As

Publication number Publication date
IL61250A (en) 1983-11-30
SU1127529A3 (ru) 1984-11-30
YU42537B (en) 1988-10-31
CA1156653A (en) 1983-11-08
PT71888B (fr) 1981-08-14
FI803221L (fi) 1981-04-12
US4356177A (en) 1982-10-26
EP0027412B1 (fr) 1983-12-14
YU21283A (en) 1983-09-30
DD153549A5 (de) 1982-01-13
NO803051L (no) 1981-04-13
PT71888A (fr) 1980-11-01
HU184330B (en) 1984-08-28
FI75339C (fi) 1988-06-09
JPS5661355A (en) 1981-05-26
ATE5561T1 (de) 1983-12-15
BR8006547A (pt) 1981-04-14
ES8200347A1 (es) 1981-11-16
CS225840B2 (en) 1984-02-13
IL61250A0 (en) 1980-12-31
AU540556B2 (en) 1984-11-22
AR231129A1 (es) 1984-09-28
ZA806180B (en) 1981-11-25
FR2467200B1 (da) 1982-07-02
JPH0115501B2 (da) 1989-03-17
DK156650C (da) 1990-02-12
GR69616B (da) 1982-07-05
NO153849B (no) 1986-02-24
NO153849C (no) 1986-06-04
IE802112L (en) 1981-04-11
DE3065906D1 (en) 1984-01-19
PH18748A (en) 1985-09-19
SU1011048A3 (ru) 1983-04-07
ES495745A0 (es) 1981-11-16
CS225823B2 (en) 1984-02-13
YU261180A (en) 1983-09-30
FI75339B (fi) 1988-02-29
NZ195233A (en) 1983-05-10
EP0027412A1 (fr) 1981-04-22
AR231975A1 (es) 1985-04-30
IE50827B1 (en) 1986-07-23
AU6328380A (en) 1981-04-30
DK156650B (da) 1989-09-18
FR2467200A1 (fr) 1981-04-17

Similar Documents

Publication Publication Date Title
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
SE423544B (sv) Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet
DK142180A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
SE7606224L (sv) Forfarande for framstellning av heterocykliska acylaminoderivat
SE430334B (sv) Forfarande for framstellning av med alkanoler foretrade metylol-aminotriaziner i form av metylol-melaminer och -bensoquanaminer
DK72476A (da) Fremgangsmade til fremstilling af tetralon- og indanonderivater
DK312878A (da) Fremgangsmaade til fremstilling af indolderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
DK428280A (da) Fremgangsmaade til fremstilling af pyridinderivater specielt med antiarytmisk virkning til modvirkning af aggregation af bldplader
DK142080A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK300978A (da) Fremgangsmaade til fremstilling af indolderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK264377A (da) Fremgangsmade til fremstilling af 1alfa-hydroxycholesterol-derivater

Legal Events

Date Code Title Description
PBP Patent lapsed